UPDATE 2-FDA panel against higher dose of Lilly-Incyte arthritis drug
April 23, 2018 at 18:44 PM EDT
* Approval in only 2 mg dose limits commercial potential- analysts
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.